Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Bird flu emergency.
View:
Post by Maxcitrac on Dec 20, 2024 11:55am

Bird flu emergency.

Dec 18, 2024...California Gov.Gavin Newsom, declared a state of emergency in response to ongoing spread of Bird Flu among dairy cattle.
California declares bird flu emergency. 1st severe human case found in Louisiana : NPR
Perfect time for Theralase to announce a Government grant on the virus front.
That would be the perfect christmas gift for all the longs on this board.
Comment by BlueFranky on Dec 20, 2024 12:01pm
Perhaps someone could send this news piece to Matt and Roger ASAP!
Comment by rollthedice10 on Dec 20, 2024 12:56pm
Don't know if TLT has the time or resources to be chasing bird flu right now. I'm happy to see TLT keep thier focus on Cancer and continue moving forward with that. The big vaccine players are no doubt all over the flu thing anyway. Focus.I have seen too many plays go sour when management loses focus or overextends themselves.  TLT has come a long way and has incredible data in regard ...more  
Comment by Eoganacht on Dec 20, 2024 1:16pm
Theralase is already in hot pursuit of a bird flu solution by way of a Collaborative Research Agreement with the government of Canada and the University if Manitoba. "Theralase® in conjunction with UM and PHAC have modified their focus to avian influenza (H5N1). These results have now laid the groundwork for the next phase of the CRA, which is evaluating the Theralase® H5N1 ...more  
Comment by rollthedice10 on Dec 20, 2024 1:29pm
I did not know this. TLT continues to amaze me! When you look at the size of Theralase you wouldn't expect them to so.. diversified. I can't wait until TLT gets the recognition it deserves and starts it's run up. Lord knows how big this could end up being. I just might pick up a few more shares while I can!
Comment by BlueFranky on Dec 20, 2024 1:40pm
Thanks for the heads up, Eoganacht. I wonder if "states of emergency" in densely populated areas such as California get the wheels turning and funds churning quicker on our front.  I can only imagine they might.
Comment by Alamir1111 on Dec 20, 2024 2:03pm
Theralase® in conjunction with UM and PHAC have modified their focus to avian influenza (H5N1).   These results have now laid the groundwork for the next phase of the CRA, which is evaluating the Theralase® H5N1 vaccine in the ability to prevent animals from contracting H5N1, when exposed to the virus, which commenced in 2Q2024 and is expected to be completed by 4Q2024."  ...more  
Comment by Alamir1111 on Dec 20, 2024 2:18pm
I get it they can only afford hatchlings  they have to be raised in house to reach maturity  that ads another 2 quarters  to study. 
Comment by tdon1229 on Dec 20, 2024 6:58pm
Declaration of emergency suspends ordinary rules re clinical trials, as for Covid when we had a National Emergency and a worldwide emergency declared.  We were under martial law, though most didn't realize it.  That's how the COVID "vaccines" were able to be developed and forced through to mass distribution without the requisite testing. The setup for the next big ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250